Gene sequencing reveals mutations in estrogen receptor responsible for breast cancer

[News]

Researchers at the University of Michigan Comprehensive Cancer Center have identified a type of mutation that develops after breast cancer patients take anti-estrogen therapies. The mutations explain one reason why patients often become resistant to this therapy. The study appears online in Nature Genetics...

More... (http://www.medicalnewstoday.com/releases/268388.php)